Calumet Specialty Products Partners, L.P. CLMT
$ 21.44
3.03%
Quarterly report 2024-Q1
added 05-10-2024
Calumet Specialty Products Partners, L.P. Balance Sheet 2011-2024 | CLMT
Annual Balance Sheet Calumet Specialty Products Partners, L.P.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.9 B | 1.58 B | 1.45 B | 1.25 B | 1.19 B | 1.45 B | 1.83 B | 1.99 B | 1.69 B | 1.7 B | 990 M | 831 M | 587 M |
Long Term Debt |
1.83 B | 1.54 B | 1.42 B | 1.32 B | 1.21 B | 1.6 B | 1.64 B | 1.99 B | 1.7 B | 1.71 B | 1.11 B | 863 M | 587 M |
Long Term Debt Current |
75.6 M | 70.7 M | 65.1 M | 41.4 M | 60.6 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 1.27 B | 1.61 B | 1.64 B | 2.01 B | 1.71 B | 1.77 B | 1.12 B | 888 M | 615 M |
Total Current Liabilities |
1.11 B | 1.35 B | 900 M | 544 M | 565 M | 415 M | 926 M | 498 M | 627 M | 544 M | 502 M | 475 M | 389 M |
Total Liabilities |
3 B | 3.03 B | 2.51 B | 1.94 B | 1.84 B | 2.02 B | 2.57 B | 2.51 B | 2.34 B | 2.31 B | 1.63 B | 1.36 B | 1 B |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
2.75 B | 2.74 B | 2.13 B | 1.81 B | 1.86 B | 2.09 B | 2.69 B | 2.73 B | 2.94 B | 3.12 B | 2.69 B | 2.25 B | 1.73 B |
Cash and Cash Equivalents |
7.9 M | 35.2 M | 38.1 M | 109 M | 19.1 M | 156 M | 164 M | 4.2 M | 5.6 M | 8.5 M | 121 M | 32.2 M | 100 K |
Book Value |
-245 M | -288 M | -385 M | -129 M | 21.6 M | 65.7 M | 120 M | 219 M | 604 M | 810 M | 1.06 B | 890 M | 729 M |
Total Shareholders Equity |
-490 M | -533 M | -385 M | -129 M | 21.6 M | 65.7 M | 120 M | 219 M | 604 M | 810 M | 1.06 B | 890 M | 729 M |
All numbers in USD currency
Quarterly Balance Sheet Calumet Specialty Products Partners, L.P.
2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.06 B | 1.61 B | 1.82 B | 1.7 B | 1.54 B | 1.44 B | - | 1.44 B | 1.42 B | 1.17 B | 1.2 B | 1.24 B | 1.32 B | 1.32 B | 1.32 B | 1.32 B | 1.21 B | 1.21 B | 1.21 B | 1.21 B | 1.6 B | 1.6 B | 1.6 B | 1.6 B | 1.64 B | 1.64 B | 1.64 B | 1.64 B | 1.99 B | 1.99 B | 1.99 B | 1.99 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.68 B | 1.71 B | 1.71 B | 1.71 B | 1.11 B | 1.11 B | 1.11 B | 1.11 B | 863 M | 863 M | 863 M | 863 M | 587 M | 587 M | 587 M | 587 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
3.02 B | 3 B | 3.1 B | 3.04 B | 3.03 B | 2.83 B | - | 2.66 B | 2.51 B | 2.13 B | 2.19 B | 2.14 B | 1.94 B | 1.94 B | 1.94 B | 1.94 B | 1.84 B | 1.84 B | 1.84 B | 1.84 B | 2.02 B | 2.02 B | 2.02 B | 2.02 B | 2.57 B | 2.57 B | 2.57 B | 2.57 B | 2.51 B | 2.51 B | 2.51 B | 2.51 B | 2.34 B | 2.34 B | 2.34 B | 2.34 B | 2.27 B | 2.31 B | 2.31 B | 2.31 B | 1.63 B | 1.63 B | 1.63 B | 1.63 B | 1.36 B | 1.36 B | 1.36 B | 1.36 B | 1 B | 1 B | 1 B | 1 B |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
2.73 B | 2.8 B | 2.8 B | 2.76 B | 2.74 B | 2.57 B | - | 2.2 B | 2.13 B | 1.83 B | 1.84 B | 1.87 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | 1.86 B | 1.86 B | 1.86 B | 1.86 B | 2.09 B | 2.09 B | 2.09 B | 2.09 B | 2.69 B | 2.69 B | 2.69 B | 2.69 B | 2.73 B | 2.73 B | 2.73 B | 2.73 B | 2.94 B | 2.94 B | 2.94 B | 2.94 B | 3.09 B | 3.12 B | 3.12 B | 3.12 B | 2.69 B | 2.69 B | 2.69 B | 2.69 B | 2.25 B | 2.25 B | 2.25 B | 2.25 B | 1.73 B | 1.73 B | 1.73 B | 1.73 B |
Cash and Cash Equivalents |
23.9 M | 13.7 M | 36 M | 11.2 M | 35.2 M | 50.5 M | 27.5 M | 10.7 M | 38.1 M | 10.8 M | 34.5 M | 114 M | 109 M | 109 M | 109 M | 109 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 156 M | 156 M | 156 M | 156 M | 164 M | 164 M | 164 M | 164 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 5.6 M | 5.6 M | 5.6 M | 5.6 M | 8.5 M | 8.5 M | 8.5 M | 8.5 M | 121 M | 121 M | 121 M | 121 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 100 K | 64 K | 64 K | 64 K |
Book Value |
-284 M | -198 M | -298 M | -276 M | -288 M | -265 M | - | -464 M | -385 M | -300 M | -352 M | -274 M | -129 M | -129 M | -129 M | -129 M | 21.6 M | 21.6 M | 21.6 M | 21.6 M | 65.7 M | 65.7 M | 65.7 M | 65.7 M | 120 M | 120 M | 120 M | 120 M | 219 M | 219 M | 219 M | 219 M | 604 M | 604 M | 604 M | 604 M | 810 M | 810 M | 810 M | 810 M | 1.06 B | 1.06 B | 1.06 B | 1.06 B | 890 M | 890 M | 890 M | 890 M | 729 M | 729 M | 729 M | 729 M |
Total Shareholders Equity |
-530 M | -448 M | -548 M | -523 M | -538 M | -465 M | -478 M | -464 M | -385 M | -300 M | -352 M | -274 M | -129 M | -129 M | -129 M | -129 M | 21.6 M | 21.6 M | 21.6 M | 21.6 M | 65.7 M | 65.7 M | 65.7 M | 65.7 M | 120 M | 120 M | 120 M | 120 M | 219 M | 219 M | 219 M | 219 M | 604 M | 604 M | 604 M | 604 M | 810 M | 810 M | 810 M | 810 M | 1.06 B | 1.06 B | 1.06 B | 1.06 B | 890 M | 890 M | 890 M | 622 M | 729 M | 729 M | 729 M | 729 M |
All numbers in USD currency